# Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness

> **NCT04272255** · PHASE3 · UNKNOWN · sponsor: **Repurposed Therapeutics, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Motion Sickness

## Interventions

- **DRUG:** scopolamine HBr
- **DRUG:** Transdermal Scopolamine

## Key facts

- **NCT ID:** NCT04272255
- **Lead sponsor:** Repurposed Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-22
- **Primary completion:** 2020-06
- **Final completion:** 2020-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272255, "Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04272255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*